Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2014
Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma
A S Gerrie, M M Power, J D Shepherd, et al.
Journal of Medical Genetics
|
May 5, 1999
A molecular and FISH analysis of structurally abnormal Y chromosomes in patients with Turner syndrome
D O Robinson, P Dalton, P A Jacobs, et al.
Journal of Medical Genetics
|
April 1, 1997
RDCI, the vasoactive intestinal peptide receptor: a candidate gene for the features of Albright hereditary osteodystrophy associated with deletion of 2q37
M M Power, R S James, J C Barber, et al.
Bone Marrow Transplantation
|
August 6, 2008
Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML
T J Nevill, D E Hogge, C L Toze, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2014
Chemoresistance can be overcome with high-dose chemotherapy and autologous stem-cell transplantation for relapsed and refractory Hodgkin lymphoma
A S Gerrie, M M Power, J D Shepherd, et al.
Journal of Medical Genetics
|
May 5, 1999
A molecular and FISH analysis of structurally abnormal Y chromosomes in patients with Turner syndrome
D O Robinson, P Dalton, P A Jacobs, et al.
Journal of Medical Genetics
|
April 1, 1997
RDCI, the vasoactive intestinal peptide receptor: a candidate gene for the features of Albright hereditary osteodystrophy associated with deletion of 2q37
M M Power, R S James, J C Barber, et al.
Bone Marrow Transplantation
|
August 6, 2008
Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML
T J Nevill, D E Hogge, C L Toze, et al.
Page
of 2